Cutler Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-400
Closed -$56K 5140
2018
Q4
$56K Sell
400
-1,100
-73% -$167K 0.01% 1403
2018
Q3
$256K Buy
1,500
+600
+67% +$101K 0.02% 722
2018
Q2
$156K Buy
+900
New +$135K 0.01% 901
2018
Q1
Sell
-226
Closed -$24K 5714
2017
Q4
$19K Sell
226
-3,000
-93% -$250K ﹤0.01% 2621
2017
Q3
$297K Buy
3,226
+1,826
+130% +$142K 0.01% 930
2017
Q2
$112K Buy
+1,400
New +$77.6K ﹤0.01% 1763

Other funds holding LOXO

Cutler Group's LOXO Position: Q1 2019 in Review

Cutler Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 400 shares — an estimated $56K sold.

Cutler Group first reported a position in LOXO in Q2 2017 and held it in 6 quarters. The position peaked at $297K in Q3 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Cutler Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 400 Loxo Oncology, Inc shares in Q1 2019, an estimated $56K.
  • Cutler Group first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 6 quarters.
  • Cutler Group's Loxo Oncology, Inc position peaked at $297K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.